Investing.com - Cerence (NASDAQ: CRNC) reported third quarter EPS of $0.19, $0.16 better than the analyst estimate of $0.03. Revenue for the quarter came in at $70.54M versus the consensus estimate of $68.4M.
Cerence's stock price closed at $2.37. It is down -55.70% in the last 3 months and down -87.87% in the last 12 months.
Cerence saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Cerence's stock price’s past reactions to earnings here.
According to InvestingPro, Cerence's Financial Health score is "fair performance".
Check out Cerence's recent earnings performance, and Cerence's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Should you invest $2,000 in CRNC right now?
With CRNC making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed CRNC alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including CRNC, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is CRNC poised for similar growth? Don't miss the opportunity to find out.
Reveal Undervalued Stocks Now